By proceeding, you agree to our Terms of Use and Privacy Policy.
Ella Ioffe is currently Director at Regeneron Pharmaceuticals.Biomedical research professional with extensive industry experience in drug discovery and development for cancer immunotherapy.
Talks About #drugdiscovery #research
Preferred Locations #NorthAmerica
With the recent clinical validation by BMS, LAG-3 combinations are spearheading the next wave of immune checkpoint inhibitors. As such, there has been an explosion of interest and high-scale investment into this exciting space.